Evidence map›Paper›PMID 38843311›Full record

ArticleDatabase : the journal of biological databases and curation2024

DRGKB: a knowledgebase of worldwide diagnosis-related groups' practices for comparison, evaluation and knowledge-guided application.

Shumin Ren, Lin Yang, Jiale Du, Mengqiao He, Bairong Shen

Abstract readComparative Study
In one paragraph

Article in Database : the journal of biological databases and curation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shumin RenDepartment of Pharmacy and Institutes for Systems Genetics, West China Hospital, Sichuan University, Frontiers Science Center for Disease-Related Molecular Network, Xinchuan Road 2222, Chengdu 610041, China.
Lin YangDepartment of Pharmacy and Institutes for Systems Genetics, West China Hospital, Sichuan University, Frontiers Science Center for Disease-Related Molecular Network, Xinchuan Road 2222, Chengdu 610041, China.
Jiale DuDepartment of Pharmacy and Institutes for Systems Genetics, West China Hospital, Sichuan University, Frontiers Science Center for Disease-Related Molecular Network, Xinchuan Road 2222, Chengdu 610041, China.
Mengqiao HeDepartment of Pharmacy and Institutes for Systems Genetics, West China Hospital, Sichuan University, Frontiers Science Center for Disease-Related Molecular Network, Xinchuan Road 2222, Chengdu 610041, China.
Bairong ShenDepartment of Pharmacy and Institutes for Systems Genetics, West China Hospital, Sichuan University, Frontiers Science Center for Disease-Related Molecular Network, Xinchuan Road 2222, Chengdu 610041, China.ORCID 0000-0003-2899-1531

Funding

National Natural Science Foundation of China 2020YFQ0019 32070671
6 · The paper itself

Abstract

As a prospective payment method, diagnosis-related groups (DRGs)'s implementation has varying effects on different regions and adopt different case classification systems. Our goal is to build a structured public online knowledgebase describing the worldwide practice of DRGs, which includes systematic indicators for DRGs' performance assessment. Therefore, we manually collected the qualified literature from PUBMED and constructed DRGKB website. We divided the evaluation indicators into four categories, including (i) medical service quality; (ii) medical service efficiency; (iii) profitability and sustainability; (iv) case grouping ability. Then we carried out descriptive analysis and comprehensive scoring on outcome measurements performance, improvement strategy and specialty performance. At last, the DRGKB finally contains 297 entries. It was found that DRGs generally have a considerable impact on hospital operations, including average length of stay, medical quality and use of medical resources. At the same time, the current DRGs also have many deficiencies, including insufficient reimbursement rates and the ability to classify complex cases. We analyzed these underperforming parts by domain. In conclusion, this research innovatively constructed a knowledgebase to quantify the practice effects of DRGs, analyzed and visualized the development trends and area performance from a comprehensive perspective. This study provides a data-driven research paradigm for following DRGs-related work along with a proposed DRGs evolution model. Availability and implementation: DRGKB is freely available at http://www.sysbio.org.cn/drgkb/. Database URL: http://www.sysbio.org.cn/drgkb/.

Indexed as

Diagnosis-Related GroupsKnowledge BasesHumans

Identifiers

PMID38843311
PMCPMC11155695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.